Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Little, Deirdre Therese ^a   Ward, Harvey Rodrick Grenville ^b  

^a Department of General Practice   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; BONE DENSITY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENARCHE; MENOPAUSAL SYNDROME; MENSTRUAL IRREGULARITY; OLIGOMENORRHEA; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; SECONDARY AMENORRHEA;

EID: 84870639919     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006879     Document Type: Article

References (4)

1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604- 6.
2. Nelson LM. Primary ovarian insufficiency. N Engl J Med 2009;360:606-14.
3. Islam R, Cartwright R. Socioeconomic Class and Smoking Linked to Premature Menopause. Presented to European Society of Human Reproduction and Embryology Conference Stockholm 6 July 2011.
4. Wise DL, Jayanthi JW, Caplanski CV, et al. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats. Birth Defects Res (Part B) 2008;83:561-72. Merck research laboratories, Westpoint, Pennsylvania.